Why is Colinz Labs falling/rising?

As of 30-Jul, Colinz Laboratories Ltd is experiencing a decline in its stock price, currently at 45.31, reflecting a decrease of 0.92 or 1.99%. The stock has been underperforming significantly, having fallen consecutively for the last seven days, resulting in a total drop of 15.81%. In the past week, the stock has decreased by 9.58%, while over the last month, it has shown a slight increase of 1.91%. However, the year-to-date performance is concerning, with a decline of 35.05%. The company's weak long-term fundamentals, including a negative CAGR growth in net sales and a poor EBIT to interest ratio, contribute to its current struggles. Additionally, the stock's low return on equity and high price-to-book value indicate expensive valuation concerns, further impacting investor sentiment.
In the broader market context, the Sensex has declined by 1.50% over the past week, suggesting that while Colinz Laboratories Ltd is underperforming, the overall market is also facing challenges. The stock's performance today has underperformed its sector by 2.33%, indicating a lack of investor confidence. The falling delivery volume, which has decreased by 87.36% against the five-day average, reflects a significant drop in investor participation, compounding the stock's difficulties. Overall, the combination of weak financial metrics and negative market sentiment has led to the stock's continued decline.